Skip to main content
INBEACON · BEACON · PHASE 1

Never miss a biopharma signal again.

Real-time intelligence from 7+ global sources, cross-source entity resolution included, delivered to where you work.

Free tier includes daily public digest · no credit card
InBeacon · Daily Digest · May 12, 2026Live
HOT
FDA approves new mAb biosimilar
Roche · CD20 · Phase 3 complete
WARM
Pfizer enters licensing deal
$150M upfront · ADC · oncology
INFO
ICH guideline Q14 v2 published
Analytical method validation · diff: 23 pp
+ 4 more signals on your watchlist
01THE PROBLEM

The intelligence you need is everywhere — and nowhere.

Every day, dozens of clinical registrations, regulatory filings, commercial deals, patents, and publications touch the molecules you care about.

They scatter across PubMed · ClinicalTrials · FDA · NMPA · EMA · FierceBiotech · SEC EDGAR · HKEX — dozens of sources.

You either spend 90 minutes a morning reading, or miss the event that matters.

PubMed
ClinicalTrials
FDA
NMPA
EMA
PMDA
SEC EDGAR
USPTO
FierceBiotech
02THE SOLUTION

One radar. Every signal.

InBeacon scans 7+ sources hourly, deduplicates, cross-source correlates, and pushes tiered summaries to where you work.

01
7+ sources
Crawled hourly
02
Hourly scan
Diff detection · dedup
03
Cross-source KG
Entities aligned across sources
04
Tiered digest
Headline → 3-line → full brief
03CAPABILITIES

Five capabilities, all in one place.

01

Subscription canvases

Keywords + companies + targets + indications + modalities + phases. Cron-level daily / weekly / real-time.

02

AI summary tiers

1-line headline → 3-sentence summary → full brief, by your reading preference.

03

Cross-source correlation

FDA approval + company PR + phase change + stock reaction → one event view.

04

Pipeline tracker

Pick company or target, get auto-built pipeline timeline. The BD anchor product.

05

Multi-channel push

Email · WeChat · DingTalk · Slack · Webhook. Delivered where you work.

04HOW IT WORKS

A 5-stage intelligence pipeline.

From crawl to digest — every signal is parsed, entities extracted, aligned across sources, and delivered in your language.

01
Crawl
Polite scrape of 7+ open sources
Crawl4AI · Playwright
02
Parse
PDFs and HTML into structured text
MinerU · Docling · GROBID
03
Extract
NER for companies, drugs, targets
GLiNER + LLM fallback
04
Align
Cross-source entity resolution into our KG
05
Distribute
Tiered AI summary in your language, pushed to your channel
05USE CASES

Who uses InBeacon.

BD
BD director at a large pharma

I track 12 competitor pipelines and 4 of our own targets. InBeacon's daily digest replaced 90 minutes of manual reading.

Anonymous · placeholder (v0)
VC
Investor at a biotech-focused VC

Pipeline tracker is the first thing I check every morning.

Anonymous · placeholder (v0)
RA
Regulatory affairs lead

Monitor FDA · NMPA guidance changes across 8 therapeutic areas without keeping 8 tabs open.

Anonymous · placeholder (v0)
06PRICING

InBeacon at every tier.

Pick a tier — InBeacon scales from a free daily digest to enterprise-wide intelligence.

Free
Public daily digest · 1 watchlist
Pro
5 watchlists · 3-company pipeline tracker
Team
25 watchlists · full pipeline tracker · Slack
Enterprise
Unlimited · private deployment option
07COMPLIANCE & DEPLOY

Available wherever your team works.

Public data only by default. Customer-uploaded watchlists are isolated per-tenant.

SaaS standard (inscinstech.ai) — default deployment
CN data residency (inscinstech.cn) — PIPL-aligned
Per-tenant isolation for watchlists and saved digests
No customer data used to train shared models
08SAMPLE OUTPUT

What a watchlist edit looks like.

app.inscinstech.ai
WATCHLIST
ADC · oncology
· Targets: HER2, TROP2, Nectin-4
· Companies: 12 tracked
· Phases: Pre-clinical → Approved
· Push: Daily · 08:00 CST
PREVIEW · LAST 24H
InBeacon · Daily Digest · May 12, 2026Live
HOT
FDA approves new mAb biosimilar
Roche · CD20 · Phase 3 complete
WARM
Pfizer enters licensing deal
$150M upfront · ADC · oncology
INFO
ICH guideline Q14 v2 published
Analytical method validation · diff: 23 pp
+ 4 more signals on your watchlist
10FAQ

Common questions

Sources are crawled hourly; new entries are indexed and pushed within 60–90 minutes of publication.
On Team and Enterprise tiers, yes — upload internal feeds or paste a URL list. They stay per-tenant.
No. Cross-source entity resolution dedupes the same event (e.g. FDA approval + company PR) into a single thread.
English and Simplified Chinese at launch. We translate the source language to your reading language.
Want to see all 4 modules in one place?Explore the full inscinstech.ai platform

Stop scrolling. Start tracking.

Free tier includes daily digest. No credit card.

Start freeBook a 15-min demo
InBeacon · Real-time biopharma intelligence agent | inscinstech.ai